201: Delivering Evidence Based Pediatric Pain Management (Rx) (AC) (CS) — Helen N. Turner, DNP, CNS, APRN, PCNS-BC, AP-PMN, FAAN
The APSNA Speaker Bureau is pleased to provide a speaker for this session.
202: Hot Topics in Pediatric Infectious Diseases — Rita Marie John, EdD, DNP, CPNP, PMHS
Our world is shrinking and new pathogens emerging in the globe involve diseases that are not commonly taught to PNPs during training. This session will focus on currently active infectious diseases in the U.S. as well as around the world. This will be taught in a case-based presentation with appropriate labs using an audience response system.
203: Immunization 2018: What NPs Who Care for Children Need to Know (Rx) — Mary Beth Koslap-Petraco, DNP, PNP-BC, CPNP, FAANP
Immunization recommendations are updated annually by the CDC. This session will advise NPs about the most current information in pediatric and adolescent immunizations using case studies. The recommended schedule, clarification of the guidelines, newly licensed vaccines and current controversies will be emphasized. Audience issues will be addressed in a question and answer session.
204: Educating Youth on the Harmful Effects of Pornography — Clay Olsen, Chief Executive Officer, Fight the New Drug
Pornography is linked to sex trafficking and affects our world as a whole. This informative, engaging and straight-forward presentation focuses on educating about the harmful effects of pornography and empowering healthcare providers with knowledge on how to protect children and teens. This presentation will help you discover what you can do to help prevent the problem of pornography from becoming a problem for children and teens in your practice.
205: Anti-Epileptic Medications (Rx) — Catherine Haut, DNP, CPNP-AC-PC, CCRN, FAANP
This presentation, intended for both acute and primary care pediatric providers, will challenge traditional treatment of seizures in children comparing previously used anti-epileptic medications with newer, evidence-based therapies. Physiology of the mechanism of action of drugs used to treat seizures will be presented along with dosing guidelines, side effects and monitoring parameters of children who are prescribed anti-epileptics.
206: Research Agenda Priority: Clinical Priorities in Adolescents — Three individual presentations.
• Reduced Hippocampal Volume is Associated with Mood and Memory Deficits in Adolescents with Single Ventricle Heart Disease Compared to Controls — Nancy Pike, PhD, CPNP-AC/PC, FAAN
• Improving Nutritional Intake in A Sample of Youth with Antipsychotic-Induced Weight Gain — Kristin Lynn Bussell, MS, PMHNP-BC
• The Essential Elements of Adolescent-Friendly Care in School-Based Health Centers: A Mixed Methods Study of the Perspectives of Nurse Practitioners and Adolescents— Alison Moriarty Daley, PhD, APRN, PNP-BC
207: ENT (Ear, Nose, Throat) Clinical Roundup — Three individual presentations.
208: Hematology and Oncology Clinical Roundup — Three individual presentations.
209: Pediatric Unintentional Injuries — Jaime Panton, DNP, APRN, CPNP
Unintentional injuries claim the lives of more children over the age of one than all other causes of childhood deaths combined. On average, 32 children die every day as a result of unintentional injury. The majority of these injuries are not simply accidents, but preventable occurrences. This presentation utilizes a case-based approach to discuss the most common mechanisms of fatal and nonfatal injuries and identify situations in which the NP can provide the most effective anticipatory guidance. This session will equip NPs practicing in primary and acute care with evidence-based interventions that can save the lives of children. Strategies to promote advocacy and policy regarding injury prevention will also be discussed.
210: Late Pre-term Infants — Christina Quick, DNP, APRN, CPNP-PC and Charlotte Rensberger, MSN, RN, CPNP-PC
This presentation is about at risk population of infants that pediatric nurse practitioners may encounter in the early neonatal period. The presentation will focus on care considerations for late pre-term following birth and after the infant’s discharge home from the hospital. Presenters will also discuss different teaching strategies for patients and families of late pre-term infants, providing examples of teaching tools developed for use in a level I nursery at a community hospital.
211: APRN Precepting: Providing the Tools for Successful Clinical Education Experiences — Beth Heuer, DNP, CRNP, CPNP-PC,PMHS; Jay M. Hunter, DNP, RN, CPNP-AC, CCRN, CPEN, CPN; Imelda Reyes, DNP, MPH, RN, APRN, CPNP-PC, FNP-BC; Maria Annette Lofgren, DNP, ARNP, NNP-BC, CPNP, FAANP; Cynthia A. Danford, PhD, CRNP, PPCNP-BC, CPNP-PC; Jessica Diver- Spruit, DNP, RN, CPNP-AC ; Daniel J. Crawford, DNP, RN, CPNP-PC; Audra N. Rankin, DNP, APRN, CPNP and Jodi Bloxham, ARNP, AC-PNP
This workshop, a joint presentation by the NAPNAP Professional Issues Committee and AFPNP, is designed to dispel APRNs’ fears of precepting and provide a ‘nuts and bolts’ approach to providing excellent clinical experiences for NP students. New and experienced preceptors will learn ways to effectively coach and communicate with students. A newly-developed Preceptor Toolkit will be introduced to further enhance attendees' expertise as mentors and preceptors.
The Association of Faculties for Pediatric Nurse Practitioners (AFPNP) is pleased to support this session.
212: Manage These Cases: Complications of Infectious Diseases (AC) — Maureen A. Madden, MSN, RN, CPNP-AC, CCRN, FCCM, Valarie Eichler, MSN, CPNP-PC/AC and Lauren R. Sorce, MSN, RN, CPNP-AC/PC, FCCM
It is important that all NPs continue to improve their knowledge, recognition and management of infectious illnesses and their complications as there is a spectrum of disease for each individual patient as well as each individual disease process, with the potential for significant long term sequelae. The key infectious disease content that will be discussed is enterovirus, human metapneumovirus, and strep pneumoniae. Each case will be presented using a case study format, which will include the presenting signs and symptoms, diagnostic evaluation, diagnostic challenges, clinical complications and therapeutic interventions. As each case progresses, didactic information will be included that will guide the attendee’s participation in the session using audience response polling and selection of case management options.
213: Taking the “itis” out of Appendicitis (AC) — Sarah Martin, RN, MS, CPNP-AC/PC and Kelly Finkbeiner, MSN, PNP
Two expert nurse practitioners will update participants on the current science of appendicitis. This session will provide the practitioner with a comprehensive, focused approach to evaluate children presenting with possible appendicitis, including laboratory tests and radiology studies. National Surgical Quality Improvement Program (NSQIP®) data will be reviewed when describing current post-op care strategies. Current research is ongoing to evaluate use of antibiotics instead of surgical intervention for acute appendicitis and findings to date will be shared. Interactive case studies will be presented to provide a forum for primary and acute care practitioners to analyze and synthesize the information gleamed from this presentation.
214: Research Agenda Priority: Clinical Priorities in Health Promotion and Disease Prevention— Three individual presentations.
• Screening for Celiac Disease in Children with Down Syndrome — Dee A. Daniels, MSN, CPNP
• The Influence of Maternal Caregiving Patterns on Indicators of Toxic Stress in Children — Eileen M. Condon, MSN, RN, FNP-BC
• Reducing Anxiety in Children Undergoing Procedures (REACH UP!): A Pilot Randomized Controlled Trial — Debra P. Shockey, DNP, RN, CPNP
215: PANDAS (Pediatric Autoimmune Neuropsychiatric Disorder Associated with Strep) (RX)— Jennifer Gagnon, MSN, CPNP, FNP-C
PANS (Pediatric Acute Onset Neuropsychiatric Syndrome) and PANDAS are becoming more widely recognized, especially since a panel of leading clinicians and researchers published revised treatment guidelines in 2017. This presentation will help you recognize when a child presents with sudden onset neuropsychiatric symptoms whether the cause may be an autoimmune response to a streptococcal or other infection. Gain the skills to recognize, diagnose and treat a child whose life changes for the worse overnight.
216: Common Pediatric Sports and Overuse Injuries — Raymond Kleposki, RN, PNP
Greater than 30 million U.S. children are involved in some kind of organized sport. Many children involved in sports will sustain some type of injury from significant trauma to mild overuse conditions. Many of these issues can affect the pediatric athlete's performance and need to be addressed by an orthopedic expert in a timely manner. The presenter will discuss the most common injuries and conditions in pediatric athletes, including presentation, diagnosis, prognosis and treatment. Conditions include significant fractures of extremities, which may or may not require surgery. Conditions can also include injuries to a pediatric athlete's spine including spondylolysis, and back sprains/strains.
217: Advocacy Clinical Roundup — Four individual presentations.
219: Sedation and Delirium Management in the PICU (AC) — Heather Herrera, MSN, RN, CPNP-AC/PC
As pediatric nurse practitioners practicing in acute care, providing adequate sedation and analgesia while also recognizing delirium is of utmost importance. Adequate sedation provides reduced anxiety, pain and agitation and can also allow invasive procedures to be performed. Delirium, which can make pediatric patients seem dazed and confused, is a global encephalopathic process that contributes to both morbidity and mortality. It is the pediatric nurse practitioner’s responsibility to provide both adequate sedation while also recognizing and understanding delirium and the medications and techniques needed for treatment.
220: Gastro Clinical Roundup — Four individual presentations.
221: Telehealth, Is That Even Legal? — Kelli Garber, MSN, PPCNP-BC
Telehealth is an innovative, efficient and effective method of providing health care. Before a nurse practitioner embraces this modality, it is important to understand what questions to ask and the implications of providing care in this manner. Telehealth laws, nurse practice acts and reimbursement policies vary by state. Because telehealth is so new, many hospitals, organizations and practices are not familiar with the important details surrounding it. This presentation will empower pediatric nurse practitioners with important information to ensure that they are well informed about the regulatory issues that surround the provision of care via telehealth.
222: It Takes Two: Partnering with Parents to Reduce Adolescent Risk — Jennifer Salerno, DNP, CPNP, FAANP
Developing effective strategies that enable honest two-way communication between nurse practitioners and their teen patients is a critical first step in preventing adolescent morbidity and mortality. Helping parents adopt these same communication strategies with their teens closes a critical gap—and strengthens the synchronization of care between NP, parent and adolescent. This session will explore 1) the social and cultural influencers contributing to adolescent risk taking 2) evidence-based techniques for connecting with teens that promote effective risk reduction communication and counseling and 3) best practices for engaging and coaching parents on positive communication with their teens.
223: Is it Nothing or Is it Cancer? — Meghan Potthoff, PhD, APRN-NP, CPNP-AC and Jacquie Hanks DNP, APRN-NP, CPNP-PC/AC
Providers are trained to think about horses, not zebras and along with this the mindset is that it is typically not cancer...but sometimes it is cancer. Through this presentation, participants will be guided through clinical scenarios where an initial diagnosis was determined to be a more likely, less threatening pediatric illness. The presentation will be presented from the pediatric hospitalist perspective and outline five real-life exemplars of patients that presented with vague clinical symptoms but ultimately were diagnosed with central nervous system tumors, lymphoma and bone malignancies.
224: The Journey of Cystic Fibrosis — Cynthia Brady, DNP, CPNP- AC
This talk traces the history of a once universally fatal childhood genetic disease as an example of how advancement in care and research has improved life expectancy and quality of life. Participants will understand how different genetic mutations affect cystic fibrosis transmembrane regulator (CFTR) function at the cell membrane that influence the pathophysiology and individualized breakthrough treatment options. A review of newborn screening allows PNPs to identify infants that require referral to a cystic fibrosis center for diagnosis and treatment. In addition, the participant will recognize that the CF care model, with its emphasis on multidisciplinary care that is driven by data from a patient registry accelerating improvements in care and outcomes, is applicable to other complex conditions.
225: Pediatric Multiple Sclerosis — Maria Milazzo, MSN, RN, PNP-BC
Although most commonly a disease of young adults, nearly 5 percent of MS patients are diagnosed prior to age 18, with some diagnosed in very early childhood. Similar to adults, the Pediatric MS population can experience difficulty with strength, balance, coordination, vision, cognition, mood and fatigue. Affected youth and families also struggle with the additional challenges of an unusual and unpredictable disease, with many “hidden symptoms”, and often report feeling isolated and lost without resources. This session will provide an overview of pediatric MS, including epidemiology, diagnosis, current treatment, educational and psychosocial impact and will include material useful for the providers in primary care, the school setting and child neurology. Using pediatric MS as a model, we will discuss strategies that can be translated to caring for children/families affected by other chronic disorders as well.
226: New Approaches to the Use of Antibiotics in the 21st Century (Rx) — Rita Olans, DNP, CPNP, APRN-BC
We all recognize the widespread development to antibiotic resistance within our practices; pharma's antibiotic pipeline is dwindling, technology and guidelines are evolving, and duration of therapy is changing. This session will review where we were, discuss where we are now, and (with the help of a cloudy crystal ball), attempt to analyze how we need to proceed in the coming years of increasing antimicrobial resistance.